INDICATIONS

• Treatment, in adults, of venous leg ulcer and/or lower limb oedemas where strong compression is recommended.

CONTRAINDICATIONS

• Moderate or severe arterial conditions, notably with recent Ankle Brachial Pressure Index (ABPI) less than 0.8
• Patients suffering from phlegmatia coerulea dolens, septic phlebitis
• Oedema from congestive cardiac failure
• Epifascial arterial bypass
• Known hypersensitivity to any of the component in UrgoK2

PRECAUTIONS

• Single use: do not wash to maintain the performances of the medical device.
• Do not sterilize.
• Do not use in direct contact with a wound.
• In the event of arterial bypass, cardiac failure, peripheral neuropathy (for example in the case of diabetes), infected peri-ulcer dermatitis or acute cellulitis (erysipelas), use the compression system after specialist referral and under close medical monitoring.
• In case of ABPI more than or equal to 1.3, suspicion of media calcific sclerosis or history of revascularization, an extensive vascular assessment is recommended before initiating the compression therapy.
• In case of infected leg ulcer, start treating infection in combination with compression therapy.
• The efficacy of UrgoK2 has been tested and validated for the application of KTech and KPress together.
• Follow the application method given to achieve the recommended therapeutic pressure. The PresSure System has been specially designed to guide the application of the bandages.
• This compression system should be worn continuously day and night until the next care at the discretion of the clinician.
• If experiencing discomfort, pain or skin reactions whilst wearing this product, patient should contact his/her healthcare professional.
• Any serious incident linked to the product must be reported to the manufacturer immediately.

For a complete list of precautions, contraindications, indications, please reach out to your local sales representative and consult the Instructions for Use (IFU)

DIRECTIONS FOR USE

PRODUCT OPTIONS

CLINICAL EVIDENCE

1.European Wound Management Association (EWMA). Position Document. Understanding compression therapy. London: MEP Ltd; 2003:13-14.

2.Meara S, et al. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2012;14;11:CD000265.

3.Lazareth I et al. Efficacy of two compression systems (UrgoKTwo vs Profore) in the local management of venous leg ulcers: Results of a European randomized controlled trial. J Wound Care 2012;21(11):553-4,556, 558

4.Junger M, et al. Comparison of interface pressures of three compression bandaging systems used on healthy volunteers. J Wound Care. 2009; 18(11):474-80.

5.Benigni JP, Lazareth I, Parpex P, et al. Efficacy, safety and acceptability of a new two-layer bandage system for venous leg ulcers. J Wound Care. 2007;16(9):385-90.

6.Hanna R, Bohbot S, Connolly N. A comparison of interface pressures of three compression bandage systems. Br J Nurs. 2008;17(20):S16-24.